Helminth egg derivatives as proregenerative immunotherapies.

Area of Science:

• Immunology and Regenerative Medicine
• Parasitology and Helminth Therapeutics

Background:

• The immune system plays a crucial role in regulating tissue repair processes.
• Current regenerative strategies often face challenges with efficacy and side effects.

Purpose of the Study:

• To develop a regenerative immunotherapy utilizing helminth-derived soluble egg antigen (SEA).
• To investigate the potential of SEA to stimulate type 2 immunity for enhanced tissue repair.
• To evaluate the efficacy and safety of this approach in preclinical injury models.

Main Methods:

• Development of regenerative SEA (rSEA) from *Schistosoma mansoni*.
• Application of rSEA to murine muscle injury models, with and without hydrogel encapsulation.
• Analysis of immune cell populations (T helper cells, eosinophils, regulatory T cells, gamma delta T cells) and cytokine profiles.
• Validation in articular joint and corneal injury models.

Main Results:

• rSEA induced accumulation of IL-4-expressing T helper cells, eosinophils, and regulatory T cells.
• rSEA decreased IL-17A expression in gamma delta T cells, promoting improved muscle repair and reduced fibrosis.
• Hydrogel-encapsulated rSEA enhanced type 2 immunity and increased tissue regeneration volume.
• rSEA demonstrated broad regenerative capacity across joint and corneal injury models.

Conclusions:

• Regenerative SEA (rSEA) represents a promising new immunotherapy for tissue repair.
• This approach leverages helminth-derived molecules to stimulate beneficial type 2 immune responses.
• Helminth derivatives offer a potential platform for developing novel regenerative therapies with reduced adverse effects.